Recognizing Osteoporosis and Its Consequences in Quebec (ROCQ) Programme

NAActive, not recruitingINTERVENTIONAL
Enrollment

2,830

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

October 31, 2007

Study Completion Date

December 31, 2025

Conditions
Osteoporosis
Interventions
BEHAVIORAL

Documentation

Participants will receive written educational material for themselves as well as the Guidelines document for their physician (same written material as in the Educational Video Group). They will be asked to revisit their physician and provide written documentation inviting him/her to consider a complementary investigation and an adequate treatment according to the 2002 Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada

BEHAVIORAL

Video

Participants will receive a 15-minute educational video on osteoporosis. They will also receive written educational material for themselves and a Guidelines document for their physician. They will be asked to revisit their physician and provide the written documentation inviting her/him to consider a complementary investigation and an adequate treatment according to the 2002 Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada. Should participants wish to obtain additional information on osteoporosis, they will be provided with a toll-free number (1-866-571-ROCQ) to contact

Trial Locations (1)

G1V 4G2

CHUdeQuebec, CHUL, Québec

Sponsors

Collaborators (3)

All Listed Sponsors
collaborator

Merck Frosst Canada Ltd.

INDUSTRY

collaborator

Sanofi

INDUSTRY

collaborator

Procter and Gamble

INDUSTRY

collaborator

Amgen

INDUSTRY

collaborator

Eli Lilly and Company

INDUSTRY

collaborator

Novartis

INDUSTRY

lead

CHU de Quebec-Universite Laval

OTHER